Metabolomics in antimicrobial drug discovery

Area of Science:

• Microbiology
• Pharmacology
• Biochemistry

Background:

• Antimicrobial resistance is a growing global health threat, necessitating novel drug discovery strategies.
• Traditional methods for antimicrobial development face challenges in identifying effective new agents.
• Metabolomics offers a powerful lens to understand microbial biochemistry and host-pathogen interactions.

Purpose of the Study:

• To review the role and applications of metabolomics in antimicrobial drug discovery and development.
• To highlight the integration of metabolomics with other omics technologies for enhanced insights.
• To discuss the potential of metabolomics in addressing the challenge of antimicrobial resistance.

Main Methods:

• Comprehensive literature search of major scientific databases (ScienceDirect, PubMed, Web of Science, Google Scholar).
• Inclusion of articles focusing on metabolomic concepts, techniques, bioinformatic tools, and their application in antimicrobial research.
• Synthesis of information on recent advancements and practical examples of metabolomics in drug discovery.

Main Results:

• Metabolomics provides essential insights into the mechanisms of action of antimicrobial compounds.
• It aids in the identification of novel drug targets and biomarkers for bacterial infections.
• The integration of metabolomics with other omics technologies offers a systems-level understanding of microbial responses.

Conclusions:

• Metabolomics is an indispensable component of modern antimicrobial drug discovery and development.
• It facilitates a mechanism-based approach, accelerating the identification and validation of new antimicrobial agents.
• Leveraging metabolomics can lead to innovative strategies for managing and controlling bacterial infections in the face of resistance.